Cargando…

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Detalles Bibliográficos
Autores principales:	NeMoyer, Rachel, Mondal, Arindam, Vora, Mehul, Langenfeld, Elaine, Glover, Danea, Scott, Michael, Lairson, Lauren, Rongo, Christopher, Augeri, David J., Peng, Youyi, Jabbour, Salma K., Langenfeld, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862756/ https://www.ncbi.nlm.nih.gov/pubmed/31744505 http://dx.doi.org/10.1186/s12964-019-0469-5

Ejemplares similares

Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2021)

Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans
por: Vora, Mehul, et al.
Publicado: (2022)

Role of Smac/DIABLO in cancer progression
por: Martinez-Ruiz, Gustavo, et al.
Publicado: (2008)

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines
por: Langenfeld, Elaine, et al.
Publicado: (2013)

Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022)

Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin
por: Langenfeld, Elaine, et al.
Publicado: (2013)

Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death
por: Augeri, Dave J., et al.
Publicado: (2016)

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
por: Xie, Wei, et al.
Publicado: (2006)

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
por: Zhao, Xiao-Yun, et al.
Publicado: (2020)

Osmostress-Induced Apoptosis in Xenopus Oocytes: Role of Stress Protein Kinases, Calpains and Smac/DIABLO
por: Messaoud, Nabil Ben, et al.
Publicado: (2015)

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
por: Pandey, Swaroop Kumar, et al.
Publicado: (2021)

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
por: Fandy, Tamer E, et al.
Publicado: (2008)

Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein
por: De Marco, Rossella, et al.
Publicado: (2020)

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients
por: Pluta, Agnieszka, et al.
Publicado: (2019)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
por: Arellano-Llamas, Abril, et al.
Publicado: (2006)

The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
por: Mariniello, Raffaela Mariarosaria, et al.
Publicado: (2020)

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression
por: SHINTANI, MICHIKO, et al.
Publicado: (2014)

Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells
por: Di Giorgio, Eros, et al.
Publicado: (2023)

Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17β-estradiol at estrus
por: Leblanc, Valerie, et al.
Publicado: (2003)

Effects of Fluid Shear Stress on Expression of Smac/DIABLO in Human Umbilical Vein Endothelial Cells()
por: Zhang, Feng, et al.
Publicado: (2013)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
por: Dobrzycka, Bozena, et al.
Publicado: (2015)

Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer
por: MIZUTANI, YOICHI, et al.
Publicado: (2012)

A Case of Midgut Volvulus Associated with a Jejunal Diverticulum
por: Gutowski, Joseph, et al.
Publicado: (2017)

A Case of Crossed Left Renal Ectopia Identified during Colostomy Reversal
por: NeMoyer, Rachel, et al.
Publicado: (2017)

Application of Flow Cytometry to Determine Differential Redistribution of Cytochrome c and Smac/DIABLO from Mitochondria during Cell Death Signaling
por: Ng, Heling, et al.
Publicado: (2012)

Monomerization of Cytosolic Mature Smac Attenuates Interaction with IAPs and Potentiation of Caspase Activation
por: Burke, Stephen P., et al.
Publicado: (2010)

2475. Hepatitis B Vaccination Coverage Amongst Asian-American Adults: A Population-Based Study of the Role of Race and Gender
por: Elsaid, Mohamed, et al.
Publicado: (2018)

Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
por: Arora, Jigyasa, et al.
Publicado: (2015)

Effect of Src Kinase inhibition on Cytochrome c, Smac/DIABLO and Apoptosis Inducing Factor (AIF) Following Cerebral Hypoxia-Ischemia in Newborn Piglets
por: Kratimenos, Panagiotis, et al.
Publicado: (2017)

CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis
por: Ibrahim, Abeer, et al.
Publicado: (2018)

CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells
por: Campbell, Grant R., et al.
Publicado: (2021)

LITESEC-T3SS - Light-controlled protein delivery into eukaryotic cells with high spatial and temporal resolution
por: Lindner, Florian, et al.
Publicado: (2020)

Diablo guardián /
por: Velasco, Xavier
Publicado: (2004)

Santos diablos
por: Álvarez Contreras, Héctor
Publicado: (2003)

Diablo guardián /
por: Velasco, Xavier
Publicado: (2006)

Diablo guardián
por: Velasco, Xavier
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_cnov4lr7ij4lr1ac2db6rijcaq